- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
前期的强势行情已经结束，投资者及时卖出股票为为宜。
- 中期趋势：
回落整理中且下跌趋势有所减缓。
- 长期趋势：
已有239家主力机构披露2025-12-31报告期持股数据，持仓量总计2.00亿股，占流通A股48.10%
- 波段诊断：
-
技术面诊股
诊断结果：5.5技术面打败了46%的股票
技术面评分前10的股票
近期的平均成本为40.04元。多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
平均成本
近期的平均成本为40.04元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"40.04","date":1777953464,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势跑输大盘，跑赢行业平均水平。
[{"date":"2026.04.30","stock":"-0.89","trade":"-0.13","ind":"-0.09"},{"date":"2026.04.29","stock":"0.05","trade":"0.19","ind":"1.96"},{"date":"2026.04.28","stock":"-2.28","trade":"0.43","ind":"-1.10"},{"date":"2026.04.27","stock":"6.21","trade":"-0.06","ind":"0.37"},{"date":"2026.04.24","stock":"-0.72","trade":"0.07","ind":"-0.69"},{"date":"2026.04.23","stock":"-1.71","trade":"-1.89","ind":"-0.88"},{"date":"2026.04.22","stock":"0.10","trade":"1.12","ind":"1.30"},{"date":"2026.04.21","stock":"-1.56","trade":"-1.11","ind":"0.10"},{"date":"2026.04.20","stock":"1.23","trade":"0.69","ind":"0.55"},{"date":"2026.04.17","stock":"-1.21","trade":"-1.80","ind":"0.60"},{"date":"2026.04.16","stock":"0.32","trade":"-0.04","ind":"2.05"},{"date":"2026.04.15","stock":"-0.37","trade":"0.14","ind":"-0.97"},{"date":"2026.04.14","stock":"1.36","trade":"1.73","ind":"1.61"},{"date":"2026.04.13","stock":"-1.02","trade":"-1.22","ind":"0.69"},{"date":"2026.04.10","stock":"1.11","trade":"0.70","ind":"2.24"},{"date":"2026.04.09","stock":"-3.40","trade":"-1.86","ind":"-0.33"},{"date":"2026.04.08","stock":"4.99","trade":"2.51","ind":"4.79"},{"date":"2026.04.07","stock":"0.36","trade":"0.66","ind":"0.36"},{"date":"2026.04.03","stock":"-3.55","trade":"-3.06","ind":"-0.99"},{"date":"2026.04.02","stock":"-1.39","trade":"-0.64","ind":"-1.60"},{"date":"2026.04.01","stock":"3.19","trade":"5.25","ind":"1.70"}]
华大基因,深证成指,医疗服务指数
压力支撑
该股压力位为40.09元，支撑位为39.70元。
[{"text":"\u538b\u529b\u4f4d","value":"40.09","date":1777478400,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"39.70","date":1777478400,"color":"0x0b52a1"}]
多空趋势
多头行情中，目前处于回落整理阶段且下跌趋势有所减缓。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.8资金面打败了50%的股票
主力控盘前10的股票
行业资金
医疗服务行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：05月06日 12:30
| 机构今日流向(万元) | -2751.99 | 机构5日流向(万元) | -5953.30 |
| 机构10日流向(万元) | -13580.70 | 机构20日流向(万元) | -18216.53 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量减少2845.05万股，其中基金净减仓34家，主力净减仓17家，请投资者中长期谨慎为宜。
截止2025-12-31，共239家主力机构（基金232家，QFII1家，一般法人5家，券商1家），持仓量总计20010.52万股，占流通A股48.10%
其中，基金持仓与2025-06-30相比：
增仓：68家 ，增持 420.63万股
减仓：102家 ，减持 278.65万股
新出现在主力名单中：55家 ，持有600.28万股
从主力名单中消失：72家 ，原持有1453.56万股
其中，基金持仓与2025-06-30相比：
增仓：68家 ，增持 420.63万股
减仓：102家 ，减持 278.65万股
新出现在主力名单中：55家 ，持有600.28万股
从主力名单中消失：72家 ，原持有1453.56万股
消息面诊股
诊断结果：5.5消息面打败了27%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 华大基因：4月30日获融资买入2086.85万元
2026-05-06 - 2026-2030年中国微生物诊断行业全景调研及投
2026-04-30 - 趋势研判！2026年全球及中国肿瘤分子检测行业产业
2026-04-30 - 华大基因：4月29日获融资买入2235.01万元
2026-04-30 - 华大基因：4月28日获融资买入1954.56万元
2026-04-29 - 【机构调研记录】嘉实基金调研华大基因、科达利等18
2026-04-29 - 华大基因获10家机构调研：公司精准医学海外业务稳步
2026-04-29 - 机构评级|华泰证券给予华大基因“增持”评级
2026-04-28 - 并购重组：万亿基金落地，十家公司最新进展
2026-04-28 - 基金调研丨银河基金调研华大基因
2026-04-28
消息列表
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-25 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-25 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-25 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-04-21 |
| 一般消息 | 高管变动 | 因个人原因 | 2026-04-10 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-03-03 |
| 一般消息 | 重大事项 | 关联交易 | 2026-02-12 |
| 利好 | 业绩预告 | 预计减亏 | 2026-01-28 |
| 一般消息 | 募资投向 | 公司出售资产 | 2026-01-28 |
| 一般消息 | 重大事项 | 关联交易 | 2026-01-28 |
| 一般消息 | 高管变动 | 工作安排 | 2026-01-27 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2026-01-05 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-12-03 |
| 一般消息 | 高管变动 | 因工作安排原因 | 2025-11-12 |
| 一般消息 | 重大事项 | 关联交易 | 2025-10-24 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-30 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-09-22 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-09-15 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-23 |
| 一般消息 | 重大事项 | 关联交易 | 2025-08-23 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-08-20 |
| 一般消息 | 资产重组 | 公司股权转让 | 2025-07-29 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-20 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-06-17 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-05-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 1条 | 0条 | 1条 |
| 利空 | 0条 | 0条 | 0条 |
行业面诊股
诊断结果：1.9行业面打败了18%的股票
医疗服务行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2026.04.30","price":"-0.09","value":"-0.13"},{"date":"2026.04.29","price":"1.96","value":"0.19"},{"date":"2026.04.28","price":"-1.10","value":"0.43"},{"date":"2026.04.27","price":"0.37","value":"-0.06"},{"date":"2026.04.24","price":"-0.69","value":"0.07"},{"date":"2026.04.23","price":"-0.88","value":"-1.89"},{"date":"2026.04.22","price":"1.30","value":"1.12"},{"date":"2026.04.21","price":"0.10","value":"-1.11"},{"date":"2026.04.20","price":"0.55","value":"0.69"},{"date":"2026.04.17","price":"0.60","value":"-1.80"},{"date":"2026.04.16","price":"2.05","value":"-0.04"},{"date":"2026.04.15","price":"-0.97","value":"0.14"},{"date":"2026.04.14","price":"1.61","value":"1.73"},{"date":"2026.04.13","price":"0.69","value":"-1.22"},{"date":"2026.04.10","price":"2.24","value":"0.70"},{"date":"2026.04.09","price":"-0.33","value":"-1.86"},{"date":"2026.04.08","price":"4.79","value":"2.51"},{"date":"2026.04.07","price":"0.36","value":"0.66"},{"date":"2026.04.03","price":"-0.99","value":"-3.06"},{"date":"2026.04.02","price":"-1.60","value":"-0.64"},{"date":"2026.04.01","price":"1.70","value":"5.25"}]
深证成指,医疗服务行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 药康生物 | 30.96% | 5.37% | 6.0分 |
| 2 | 普瑞眼科 | 29.90% | 18.74% | 6.6分 |
| 3 | 爱尔眼科 | 11.25% | 3.55% | 5.3分 |
| 4 | 华康洁净 | 9.45% | -5.42% | 4.4分 |
| 5 | 百诚医药 | 8.46% | 2.40% | 5.5分 |
| 6 | 奥浦迈 | 8.16% | 1.01% | 4.8分 |
| 8 | 药明康德 | 5.53% | 9.34% | 6.0分 |
| 10 | 毕得医药 | 4.17% | 10.47% | 5.5分 |
| 12 | 博济医药 | 3.47% | 6.34% | 5.8分 |
| 14 | 成都先导 | 2.73% | 6.71% | 6.3分 |
| 16 | 金域医学 | 1.71% | -4.91% | 4.7分 |
| 18 | 迪安诊断 | 0.73% | -0.15% | 5.9分 |
| 20 | 大东方 | 0.00% | 7.30% | 5.4分 |
| 22 | 何氏眼科 | -1.44% | 4.25% | 5.7分 |
| 24 | 光正眼科 | -1.78% | 8.89% | 6.3分 |
| 26 | 华大基因 | -2.87% | 2.17% | 4.8分 |
| 28 | 康龙化成 | -3.52% | -1.05% | 4.6分 |
| 30 | ST中珠 | -3.97% | -5.67% | 4.5分 |
| 32 | 益诺思 | -4.79% | -1.46% | 4.9分 |
| 34 | 三博脑科 | -5.39% | -4.51% | 4.6分 |
| 36 | 泓博医药 | -5.46% | -3.23% | 5.3分 |
| 38 | 和元生物 | -6.09% | 1.95% | 4.2分 |
| 40 | 贝瑞基因 | -6.81% | 2.99% | 5.1分 |
| 42 | *ST生物 | -8.93% | -2.65% | 4.9分 |
| 44 | - | -10.25% | -13.78% | 分 |
| 46 | 普蕊斯 | -11.13% | -6.78% | 5.0分 |
| 48 | 百花医药 | -12.10% | -2.54% | 4.2分 |
| 50 | 盈康生命 | -15.41% | -1.66% | 5.1分 |
| 52 | 睿智医药 | -19.57% | -6.29% | 4.5分 |
| 54 | 九洲药业 | -22.27% | -16.63% | 4.2分 |
| 56 | 诚达药业 | -30.82% | 3.18% | 4.6分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 43/102 ， 22/102。
[{"date":"2026-03-31","value":"-0.11","vol":"0.96"},{"date":"2025-12-31","value":"-7.00","vol":"2.21"},{"date":"2025-09-30","value":"-0.23","vol":"3.24"},{"date":"2025-06-30","value":"0.06","vol":"2.24"},{"date":"2025-03-31","value":"-0.58","vol":"0.88"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-0.11 | -7.00 | -0.23 | 0.06 | -0.58 |
| 行业(%) | 0.96 | 2.21 | 3.24 | 2.24 | 0.88 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"39.71","vol":"34.16"},{"date":"2025-12-31","value":"37.59","vol":"34.36"},{"date":"2025-09-30","value":"42.97","vol":"36.06"},{"date":"2025-06-30","value":"44.65","vol":"36.21"},{"date":"2025-03-31","value":"43.55","vol":"35.05"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
39.71 | 37.59 | 42.97 | 44.65 | 43.55 |
| 行业(%) | 34.16 | 34.36 | 36.06 | 36.21 | 35.05 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 14/102 ， 17/102。
[{"date":"2026-03-31","value":"20.35","vol":"16.75"},{"date":"2025-12-31","value":"-4.18","vol":"8.22"},{"date":"2025-09-30","value":"-5.39","vol":"3.06"},{"date":"2025-06-30","value":"-12.82","vol":"2.87"},{"date":"2025-03-31","value":"-18.18","vol":"-0.73"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
20.35 | -4.18 | -5.39 | -12.82 | -18.18 |
| 行业(%) | 16.75 | 8.22 | 3.06 | 2.87 | -0.73 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"81.93","vol":"79.49"},{"date":"2025-12-31","value":"31.69","vol":"23.26"},{"date":"2025-09-30","value":"82.78","vol":"20.05"},{"date":"2025-06-30","value":"-68.25","vol":"-63.31"},{"date":"2025-03-31","value":"-524.87","vol":"-22.07"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
81.93 | 31.69 | 82.78 | -68.25 | -524.87 |
| 行业(%) | 79.49 | 23.26 | 20.05 | -63.31 | -22.07 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 42/102 ， 32/102。
[{"date":"2026-03-31","value":"0.07","vol":"0.10"},{"date":"2025-12-31","value":"0.31","vol":"0.44"},{"date":"2025-09-30","value":"0.22","vol":"0.32"},{"date":"2025-06-30","value":"0.13","vol":"0.21"},{"date":"2025-03-31","value":"0.05","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.07 | 0.31 | 0.22 | 0.13 | 0.05 |
| 行业(次) | 0.10 | 0.44 | 0.32 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"1.03","vol":"3.44"},{"date":"2025-12-31","value":"4.28","vol":"15.84"},{"date":"2025-09-30","value":"2.72","vol":"10.95"},{"date":"2025-06-30","value":"1.55","vol":"7.15"},{"date":"2025-03-31","value":"0.65","vol":"3.62"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
1.03 | 4.28 | 2.72 | 1.55 | 0.65 |
| 行业(次) | 3.44 | 15.84 | 10.95 | 7.15 | 3.62 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"-22.43","vol":"0.86"},{"date":"2025-12-31","value":"36.20","vol":"20.95"},{"date":"2025-09-30","value":"-2.19","vol":"16.52"},{"date":"2025-06-30","value":"-1.75","vol":"16.38"},{"date":"2025-03-31","value":"-59.10","vol":"-0.79"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | -22.43 | 36.20 | -2.19 | -1.75 | -59.10 |
| 行业 | 0.86 | 20.95 | 16.52 | 16.38 | -0.79 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.89","vol":"0.89"},{"date":"2025-09-30","value":"","vol":"0.01"},{"date":"2025-06-30","value":"0.97","vol":"0.91"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.89 | - | 0.97 | - |
| 行业 | 0.00 | 0.89 | 0.01 | 0.91 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 18/102 ， 35/102。
[{"date":"2026-03-31","value":"2.60","vol":"3.37"},{"date":"2025-12-31","value":"2.42","vol":"3.64"},{"date":"2025-09-30","value":"2.81","vol":"3.67"},{"date":"2025-06-30","value":"2.81","vol":"3.57"},{"date":"2025-03-31","value":"2.85","vol":"3.68"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
2.60 | 2.42 | 2.81 | 2.81 | 2.85 |
| 行业 | 3.37 | 3.64 | 3.67 | 3.57 | 3.68 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"2.31","vol":"2.78"},{"date":"2025-12-31","value":"2.18","vol":"3.00"},{"date":"2025-09-30","value":"2.49","vol":"2.94"},{"date":"2025-06-30","value":"2.49","vol":"2.87"},{"date":"2025-03-31","value":"2.52","vol":"2.97"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.31 | 2.18 | 2.49 | 2.49 | 2.52 |
| 行业 | 2.78 | 3.00 | 2.94 | 2.87 | 2.97 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 31/102 ， 35/102。
[{"date":"2026-03-31","value":"24.73","vol":"32.97"},{"date":"2025-12-31","value":"26.74","vol":"32.98"},{"date":"2025-09-30","value":"23.82","vol":"32.60"},{"date":"2025-06-30","value":"24.81","vol":"33.58"},{"date":"2025-03-31","value":"26.68","vol":"32.05"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
24.73 | 26.74 | 23.82 | 24.81 | 26.68 |
| 行业(%) | 32.97 | 32.98 | 32.60 | 33.58 | 32.05 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.33","vol":"0.97"},{"date":"2025-12-31","value":"0.37","vol":"0.97"},{"date":"2025-09-30","value":"0.32","vol":"0.92"},{"date":"2025-06-30","value":"0.33","vol":"0.96"},{"date":"2025-03-31","value":"0.37","vol":"0.96"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.33 | 0.37 | 0.32 | 0.33 | 0.37 |
| 行业(%) | 0.97 | 0.97 | 0.92 | 0.96 | 0.96 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"8.03","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"0.93","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-9.03","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-6.17","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"-0.01","blueLineValue":"-0.00","type":"YC"}]